< Back to H.R. 1746 (108th Congress, 2003–2004)

Text of the Breast Cancer and Environmental Research Act of 2003

This bill was introduced on April 10, 2003, in a previous session of Congress, but was not enacted. The text of the bill below is as of Apr 10, 2003 (Introduced).

Source: GPO

HR 1746 IH

108th CONGRESS

1st Session

H. R. 1746

To amend the Public Health Service Act to authorize the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer.

IN THE HOUSE OF REPRESENTATIVES

April 10, 2003

Mrs. LOWEY (for herself, Mrs. MYRICK, Ms. NORTON, Mr. LYNCH, Mr. KILDEE, Mrs. MCCARTHY of New York, Mr. MCNULTY, Ms. WOOLSEY, Mr. BROWN of Ohio, Mr. MCINTYRE, Mr. GUTIERREZ, Mr. HOLDEN, Mr. FRANK of Massachusetts, Mr. WILSON of South Carolina, Mr. FROST, Mr. WOLF, Mr. MCHUGH, Mr. TIERNEY, Mr. HOLT, Mr. MCDERMOTT, Mr. RODRIGUEZ, Ms. BORDALLO, Mr. GREEN of Texas, Mr. BAKER, Mr. SENSENBRENNER, Mr. GORDON, Ms. BERKLEY, Mr. ROTHMAN, Mr. DAVIS of Illinois, Mr. BERMAN, Mr. NADLER, Mr. OWENS, Mr. HINCHEY, Mr. RYAN of Ohio, Mr. SCHIFF, Mrs. CAPPS, Mr. OBERSTAR, Mr. BOSWELL, Mr. OSE, Ms. SCHAKOWSKY, Mr. SIMMONS, Ms. CARSON of Indiana, Mr. SANDERS, Mr. BISHOP of New York, Mr. REYES, Mr. STARK, Mr. ACKERMAN, Mrs. MUSGRAVE, Mr. UDALL of Colorado, Mr. MEEHAN, Mr. CLYBURN, Mr. GEORGE MILLER of California, Mr. DOYLE, Ms. MILLENDER-MCDONALD, Mr. WAXMAN, Mr. BASS, Mr. SHAYS, Mr. LEACH, Mr. EVANS, and Ms. DELAURO) introduced the following bill; which was referred to the Committee on Energy and Commerce


A BILL

To amend the Public Health Service Act to authorize the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer.

    Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ‘Breast Cancer and Environmental Research Act of 2003’.

SEC. 2. FINDINGS.

    The Congress finds as follows:

      (1) Breast cancer is the second leading cause of cancer deaths among American women.

      (2) More women in the United States are living with breast cancer than any other cancer (excluding skin cancer). Approximately 3 million women in the United States are living with breast cancer: 2 million who have been diagnosed and an estimated 1 million who do not yet know they have the disease.

      (3) Breast cancer is the most commonly diagnosed cancer among women in the United States and worldwide (excluding skin cancer). In 2001, it is estimated that 233,000 new cases of breast cancer will be diagnosed among women in the United States: 192,000 invasive breast cancer and 40,800 cases of ductal carcinoma in situ (DCIS).

      (4) Breast cancer is the second leading cause of breast cancer death for women in the United States; approximately 40,000 women in the U.S. die from the disease each year. Breast cancer is the leading cause of cancer death for U.S. women between the ages of 20 and 59, and the leading cause of cancer death for women worldwide.

      (5) A woman in the United States has a 1 in 8 chance of developing invasive breast cancer in her lifetime--this risk was 1 in 11 in 1975. In 2001, a new case of breast cancer will be diagnosed every 2 minutes, and a woman will die from breast cancer every 13 minutes.

      (6) All women are at risk for breast cancer. About 90 percent of women who develop breast cancer do not have a family history of the disease.

      (7) The National Action Plan on Breast Cancer, a public-private partnership, has recognized the importance of expanding the scope and breadth of biomedical, epidemiological, and behavioral research activities related to the etiology of breast cancer and the role of the environment.

      (8) To date, there has been only a limited research investment to expand the scope or coordinate efforts across disciplines or work with the community to study the role of the environment in the development of breast cancer.

      (9) In order to take full advantage of the tremendous potential for avenues of prevention, the Federal investment in the role of the environment

and the development of breast cancer should be expanded.

      (10) In order to understand the effect of chemicals and radiation on the development of cancer, multi-generational, prospective studies are probably required.

SEC. 3. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES; AWARDS FOR DEVELOPMENT AND OPERATION OF RESEARCH CENTERS REGARDING ENVIRONMENTAL FACTORS RELATED TO BREAST CANCER.

    Subpart 12 of part C of title IV of the Public Health Service Act (42 U.S.C. 285l et seq.) is amended by adding at the end the following section:

‘SEC. 463B. RESEARCH CENTERS REGARDING ENVIRONMENTAL FACTORS RELATED TO BREAST CANCER.

    ‘(a) IN GENERAL- The Director of the Institute, based on recommendations from the Breast Cancer and Environmental Research Advisory Panel (hereafter in this section referred to as the ‘Panel’), shall make grants, after a process of peer review and programmatic review, to public or nonprofit private entities for the development and operation of not more than 8 centers for the purpose of conducting multidisciplinary and multi-institutional research on environmental factors that may be related to the etiology of breast cancer. Each such center shall be known as a Breast Cancer and Environmental Research Center of Excellence. The Panel shall oversee the peer review process and shall conduct a programmatic review. The Panel will recommend the funding criteria and mechanisms by which the grant funds shall be allocated. The Panel shall make final programmatic recommendations on allocation of grant funds.

    ‘(b) BREAST CANCER AND ENVIRONMENTAL RESEARCH ADVISORY PANEL-

      ‘(1) IN GENERAL- The Secretary shall establish in the Institute of Environmental Health Sciences the Breast Cancer and Environmental Research Panel (hereafter in this section individually referred to as the ‘Panel’).

      ‘(2) MEMBERSHIP- The Panel shall be composed of nine appointed members and nonvoting ex officio members. The Secretary shall appoint--

        ‘(A) six members from physicians, and other health professionals, who are not officers or employees of the United States, and who represent multiple disciplines, including clinical, basic and public health sciences, and also different geographical regions of the country, individuals shall come from practice settings as well as academia and other research settings. Panel members should be experienced in biomedical review; and

        ‘(B) three members from the general public who are consumer representatives who have had breast cancer and who represent a constituency.

      ‘(3) CHAIR- The members of the Panel shall select a chairman from among the appointed members.

      ‘(4) MEETINGS- The Panel shall meet at the call of the chairman or upon the request of the Director of the Institute, but not less often than once a year.

    ‘(c) COLLABORATION WITH COMMUNITY- Each center under subsection (a) shall establish and maintain ongoing collaborations with community organizations in the geographic area served by the center, including those that represent women with breast cancer.

    ‘(d) COORDINATION OF CENTERS; REPORTS- The Director of the Institute shall, as appropriate, provide for the coordination of information among centers under subsection (a) and ensure regular communication between such centers, and may require the periodic preparation of reports on the activities of the centers and the submission of the reports to the Director.

    ‘(e) REQUIRED CONSORTIUM- Each center under subsection (a) shall be formed from a consortium of cooperating institutions, meeting such requirements as may be prescribed by the Director of the Institute. Each center must require collaboration among highly accomplished scientists, other health professionals and advocates of diverse backgrounds from various areas of expertise.

    ‘(f) DURATION OF SUPPORT- Support of a center under subsection (a) may be for a period not exceeding 5 years. Such period may be extended for one or more additional periods not exceeding 5 years if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director of the Institute and if such group has recommended to the Director that such period should be extended.

    ‘(g) GEOGRAPHIC DISTRIBUTION OF CENTERS- The Director of the Institute shall, to the extent practicable, provide for an equitable geographical distribution of centers under this section.

    ‘(h) INNOVATIVE APPROACHES- Centers shall use innovative approaches to study unexplored or under explored areas of the environment and breast cancer.

    ‘(i) AUTHORIZATION OF APPROPRIATIONS- For the purpose of carrying out this section, there is authorized to be appropriated $30,000,000 for each of the fiscal years 2004 through 2009. Such authorization is in addition to any other authorization of appropriations that is available for such purpose.’.